The aim is to provide training to practitioners in RegenLab’s patented PRP technology.

RegenLab a Swiss manufacturer of Class IIb & III medical devices for autologous blood cell preparations, hyaluronic acid, and bone marrow cell extracts – has announced a partnership with the independent training provider, Acquisition Aesthetics. 

Through the partnership, Acquisition Aesthetics’ nationwide network of practitioners will be able to undertake an educational course on RegenLab’s patented PRP technology.

RegenLab has established itself as an authority on Platelet-Rich-Plasma (PRP), with CE certifications and registration with regulatory bodies around the world. The company has more than 200 publications and multiple clinical studies to its name.

Acquisition Aesthetics already offers a wealth of hands-on training courses, including the Level seven Diploma in aesthetic medicine, across five national training sites. It aims to improve the standards of non-surgical aesthetics practice in the UK.

“We are very much looking forward to working with Acquisition Aesthetics, to showcase the power of our PRP devices and the fantastic results they produce,” said the deputy director at RegenLab, Carlo Turzi.

“Acquisition Aesthetics is immensely proud to be launching this new and exciting educational opportunity to our nationwide network of aestheticians,” commented the co-director at Acquisition Aesthetics, Dr Lara Watson. “We’ve seen a growing interest in PRP therapy over recent years and we are pleased to be offering this course in partnership with such a trusted and reputable provider of PRP technology.”

The partnership will also allow RegenLab to educate practitioners on its latest innovations. That includes DERMAL, a product used to treat acne scarring and keloid scarring, and Cellular Matrix – a patented application that combines PRP with HA to enhance molecule activity in PRP. This helps to achieve natural-looking improvements in skin tone, laxity and contouring. 

RegenLab’s PRP technology can also help boost hair density in patients with androgenetic alopecia by increasing blood flow and follicular cell proliferation. Moreover, it can be used to treat lichen sclerosis as well as male and female sexual dysfunction to improve desire, arousal, lubrication, and orgasm.

For more information on the course, visit acquisitionaesthetics.co.uk/course/platelet-rich-plasma-prp-training-course/

SOURCEAesthetics Medicine
Previous articleCrown Aesthetics Expands Further Into the APAC Region
Next articleCroma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China